The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A retrospective analysis of clinical factors influencing response to treatment with cabazitaxel in patients with metastatic castration resistant prostate cancer.
 
Nimira S. Alimohamed
No Relationships to Disclose
 
Daniel Yokom
No Relationships to Disclose
 
Eric Winquist
Research Funding - Astellas Pharma (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Medivation (Inst); Oncogenex (Inst); Oncolytics (Inst); Oncothyreon (Inst); Roche (Inst); Sanofi (Inst)
 
Scott R. Berry
Honoraria - Astellas Pharma; Sanofi
Consulting or Advisory Role - Sanofi
 
Stacey Hubay
No Relationships to Disclose
 
Jean-Baptiste Lattouf
No Relationships to Disclose
 
Helene Leonard
No Relationships to Disclose
 
Carla Girolametto
No Relationships to Disclose
 
Fred Saad
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Novartis; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bavarian Nordic; Janssen Oncology; Millennium; Novartis; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Oncogenex (Inst); Sanofi (Inst)
 
Srikala S. Sridhar
Honoraria - Astellas Pharma; Janssen; Sanofi
Consulting or Advisory Role - Astellas Pharma; Janssen; Sanofi
Research Funding - Astellas Pharma; Janssen; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; Sanofi